{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59.5"}]}],"title":"Week 24 (n = 1984)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"52.5"}]}],"title":"Week 36 (n = 1839)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.0"}]}],"title":"Week 48 (n = 1803)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.8"}]}],"title":"Week 108 (n = 1616)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.3"}]}],"title":"Week 156 (n = 1513)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.4"}]}],"title":"Week 204 (n = 1422)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"61.9"}]}],"title":"Week 264 (n = 1320)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"2067"}],"units":"Participants"}],"description":"The FACIT-F is a 13-item participant self-report questionnaire that assesses fatigue over the previous 7 days by scoring each item on a 5-point scale (0=Not at all, 1=A little bit, 2=Somewhat, 3=Quite a bit, 4=Very much). An overall FACIT-F score was obtained by summing the scores of all 13 items. The overall score ranged from 0 to 52. A lower score indicates less fatigue. A clinically relevant improvement in the FACIT-F score was defined as a ≥ 5-point increase from Baseline.","groups":[{"description":"Participants received tocilizumab 8 mg/kg intravenously every 4 weeks till the end of the study (up to 7 years, 7 months). In addition, participants may have also received disease-modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs, and oral corticosteroids at the discretion of the investigator.","id":"OG000","title":"Tocilizumab"}],"paramType":"NUMBER","populationDescription":"All-exposure population: All participants who entered this study and received at least 1 dose of tocilizumab in either this extension study or in a core study. Only participants with available data were included in the analysis.","timeFrame":"Baseline to Week 264","title":"Percentage of Participants With a Clinically Relevant Improvement in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) Score at Weeks 24, 36, 48, 108, 156, 204, and 264","type":"SECONDARY","unitOfMeasure":"Percentage of participants"}